Article Details
Retrieved on: 2022-11-02 06:55:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CSL says it is paying $US200 million ($A312m) up-front to license next-generation mRNA vaccine technology from a small US company.
Article found on: au.finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here